Zhejiang Jolly Pharmaceutical Co.,Ltd.’s Net Profit Rose 36.7% in First Quarter of 2023

Zhejiang Jolly Pharmaceutical Co.,Ltd. (浙江佐力药业股份有限公司) (300181.SZ) reported a net profit of 99.5 million yuan in the first quarter of 2023, up 36.7% year-on-year.

Meanwhile, the company posted 495.7 million yuan in revenue, up 12.8% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 785.6 million yuan in total liabilities, with a liability-to-asset ratio of 21.8%.